The Evolving Landscape of Respiratory Syncytial Virus (RSV) Prophylaxis in Infants. [PDF]
Chamarthi S, Gupta S, Chamarthi VS.
europepmc +1 more source
Palivizumab for Severe Respiratory Syncytial Virus Infection in Immunocompetent Adults: A Case Series. [PDF]
Zhong JY +5 more
europepmc +1 more source
Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody. [PDF]
Farías MA +16 more
europepmc +1 more source
Strengthening RSV prevention in early life through new generation strategies. [PDF]
Mejias A, Ramilo O.
europepmc +1 more source
Insights into epidemiological and clinical burden of bronchiolitis among hospitalized children: a call for preventive interventions. [PDF]
Abughosh R +7 more
europepmc +1 more source
Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis. [PDF]
Sauré D +10 more
europepmc +1 more source
Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges. [PDF]
Liu H, Zhong H, Liu H.
europepmc +1 more source
Analysis of the economically justifiable price of nirsevimab to prevent respiratory syncytial virus infection in Korea. [PDF]
Han HJ +7 more
europepmc +1 more source
Is Palivizumabe a Protective Factor for the Development of Asthma in Children? A Systematic Review With Metanalysis. [PDF]
Manini MB +4 more
europepmc +1 more source
Discovery and molecular mechanism of potent neutralizing antibody from humanized mice with respiratory syncytial virus. [PDF]
Zhang Z +11 more
europepmc +1 more source

